Breaking News Instant updates and real-time market news.

ICPT

Intercept

$96.20

0.45 (0.47%)

05:01
09/20/17
09/20
05:01
09/20/17
05:01

Intercept recent pullback a buying opportunity, says Jefferies

After hosting investor meetings with management, Jefferies analyst Michael Yee says the recent pullback in shares of Intercept Pharmaceuticals creates a buying opportunity. The analyst left the meetings more confident that the Street's reaction to the patient safety letter "was overblown and likely to subside." The stock is near a "floor valuation" of $80-$100 and gives no credit to nonalcoholic steatohepatitis in 2019, Yee tells investors in a research note. He keeps a Buy rating on Intercept with a $275 price target.

ICPT Intercept
$96.20

0.45 (0.47%)

09/19/17
SBSH
09/19/17
NO CHANGE
Target $150
SBSH
Buy
Concern over Intercept 'Dear Doctor' letter overblown, says Citi
After finding 10 other drugs that have been the subject of a "Dear Doctor" letter related to liver toxicity issues, Citi analyst Joel Beatty believes concern over Intercept Pharmaceuticals' patient safety letter on Ocaliva is overblown. The risk that Ocaliva will be withdrawn from the market is "very low," and the risk that the drug will get a black box warning isn't as much of a given as it first appear, Beatty tells investors in a research note. Further, he believes the drug can still be commercially successful even with a black box warning. The analyst keeps a Buy rating on Intercept with a $150 price target.
09/14/17
RBCM
09/14/17
INITIATION
Target $244
RBCM
Outperform
Intercept initiated with an Outperform at RBC Capital
RBC Capital analyst Brian Abrahams started Intercept Pharmaceuticals with an Outperform rating and $244 price target. After speaking to physicians, the analyst believes Ocaliva's prospects in cholestatic disease are underappreciated and the drug's long-term potential in nonalcoholic Steatohepatitis "could be substantial." He views the stock as "meaningfully undervalued."
09/14/17
OPCO
09/14/17
NO CHANGE
Target $15
OPCO
Outperform
Intercept Ocaliva dynamics highlight PBC opportunity, says Oppenheimer
Oppenheimer analyst Jay Olson says the Dear Doctor letter for Intercept's (ICPT) Ocaliva raises awareness of unmet medical need for patients with primary biliary cholangitis, or PBC. Since patients with Child-Pugh B/C cirrhosis were not studied in Ocaliva trials, the analyst believes the FDA's collaboration with Intercept to leverage PK modeling for dosing guidance which is included in the label and emphasized in the Dear Doctor letter highlights the importance of providing novel treatments to PBC patients. Olson expects these events to have a positive impact on the treatment of all PBC patients, and says CymaBay (CBAY) may benefit from these dynamics. He reiterates an Outperform rating and $15 price target on CymaBay's shares.
09/13/17
JMPS
09/13/17
NO CHANGE
Target $150
JMPS
Outperform
Intercept letter doesn't change fundamental view of Ocaliva, says JMP Securities
JMP Securities analyst Liisa Bayko said the warning letter sent by Intercept to health care providers regarding post-marketing reports of liver issues and death in certain PBC patients highlights risks that were already known and doesn't change her fundamental view on Ocaliva. The analyst, who sees little read through to the ongoing Phase 3 REGENERATE trial in NASH patients and views yesterday's drop in Intercept shares as an overreaction, keeps an Outperform rating and $150 price target on the stock.

TODAY'S FREE FLY STORIES

MERC

Mercer

$13.50

-0.05 (-0.37%)

20:51
10/18/17
10/18
20:51
10/18/17
20:51
Upgrade
Mercer rating change  »

Mercer upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Oct

ADBE

Adobe

$153.00

2.62 (1.74%)

20:50
10/18/17
10/18
20:50
10/18/17
20:50
Upgrade
Adobe rating change  »

Adobe upgraded to Hold…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

  • 22

    Oct

  • 06

    Nov

MDB

MongoDB

20:46
10/18/17
10/18
20:46
10/18/17
20:46
Syndicate
MongoDB 8M share IPO priced at $24.00 »

The deal priced above the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

VZ

Verizon

$48.65

0.25 (0.52%)

, PM

Philip Morris

$112.51

-0.14 (-0.12%)

20:25
10/18/17
10/18
20:25
10/18/17
20:25
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

VZ

Verizon

$48.65

0.25 (0.52%)

PM

Philip Morris

$112.51

-0.14 (-0.12%)

DHR

Danaher

$86.05

0.79 (0.93%)

BK

BNY Mellon

$54.46

0.5 (0.93%)

BX

Blackstone

$33.49

0.27 (0.81%)

BBT

BB&T

$46.54

0.02 (0.04%)

TRV

Travelers

$130.02

1.37 (1.06%)

PPG

PPG

$112.88

-0.08 (-0.07%)

RCI

Rogers Communications

$53.75

-0.23 (-0.43%)

NUE

Nucor

$57.28

0.17 (0.30%)

DOV

Dover

$93.57

-0.48 (-0.51%)

GPC

Genuine Parts

$98.04

1.18 (1.22%)

TXT

Textron

$53.57

0.5 (0.94%)

DGX

Quest Diagnostics

$92.05

-0.13 (-0.14%)

ADS

Alliance Data

$228.38

1.44 (0.63%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 19

    Oct

  • 19

    Oct

  • 19

    Oct

  • 19

    Oct

  • 19

    Oct

  • 19

    Oct

  • 19

    Oct

  • 19

    Oct

  • 19

    Oct

  • 19

    Oct

  • 19

    Oct

  • 19

    Oct

  • 19

    Oct

  • 19

    Oct

  • 22

    Oct

  • 30

    Oct

  • 01

    Nov

  • 06

    Nov

  • 07

    Nov

  • 13

    Nov

  • 16

    Nov

  • 29

    Nov

  • 30

    Nov

  • 14

    Dec

HPE

HP Enterprise

$14.70

0.09 (0.62%)

19:12
10/18/17
10/18
19:12
10/18/17
19:12
Hot Stocks
HP Enterprise raises share buyback by $5B, raises regular dividend 15% »

Given HPE's strong…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

  • 11

    Dec

HPE

HP Enterprise

$14.70

0.09 (0.62%)

19:11
10/18/17
10/18
19:11
10/18/17
19:11
Hot Stocks
HPE to simplify organizational structure, to drive cost savings of $1.5B »

HPE President Antonio…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

  • 11

    Dec

HPE

HP Enterprise

$14.70

0.09 (0.62%)

19:10
10/18/17
10/18
19:10
10/18/17
19:10
Earnings
HP Enterprise sees FY17 adjusted EPS view roughly $1.00, consensus $1.40 »

Sees FY17 revenue growth…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

  • 11

    Dec

HPE

HP Enterprise

$14.70

0.09 (0.62%)

19:08
10/18/17
10/18
19:08
10/18/17
19:08
Earnings
HP Enterprise sees FY18 adjusted EPS $1.15-$1.25, consensus $1.20 »

HPE expects its non-GAAP…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

  • 11

    Dec

CME

CME Group

$136.37

0.18 (0.13%)

19:01
10/18/17
10/18
19:01
10/18/17
19:01
Hot Stocks
CME Group, JPX enter agremenet to launch TOPIX futures contract on CME »

CME Group and Japan…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

  • 26

    Oct

  • 07

    Nov

UAL

United Continental

$67.99

0.48 (0.71%)

18:50
10/18/17
10/18
18:50
10/18/17
18:50
Hot Stocks
Breaking Hot Stocks news story on United Continental »

United Continental sees…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

CSX

CSX

$53.68

-0.55 (-1.01%)

18:49
10/18/17
10/18
18:49
10/18/17
18:49
Hot Stocks
CSX discloses reduction of locomotives in maintenance program »

According to a regulatory…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

  • 30

    Oct

VZ

Verizon

$48.65

0.25 (0.52%)

18:41
10/18/17
10/18
18:41
10/18/17
18:41
Periodicals
Verizon targets spring 2018 start of delayed online TV service, Bloomberg says »

Verizon is targeting a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 01

    Nov

IBM

IBM

$159.53

12.99 (8.86%)

18:37
10/18/17
10/18
18:37
10/18/17
18:37
Hot Stocks
IBM CFO: Great start to 2H17 »

Says dollar is important…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 15

    Nov

SEAS

SeaWorld

$12.31

-0.17 (-1.36%)

18:26
10/18/17
10/18
18:26
10/18/17
18:26
Hot Stocks
SeaWorld to eliminate approximately 350 positions in restructuring program »

On October 18, SeaWorld…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Nov

JPM

JPMorgan

$97.99

0.37 (0.38%)

18:12
10/18/17
10/18
18:12
10/18/17
18:12
Hot Stocks
SEC names JPMorgan exec Redfearn Director of Division of Trading and Markets »

The Securities and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

  • 20

    Oct

  • 22

    Oct

  • 23

    Oct

  • 02

    Nov

  • 05

    Nov

  • 27

    Feb

  • 13

    Apr

  • 14

    Jul

  • 12

    Oct

VZ

Verizon

$48.65

0.25 (0.52%)

18:10
10/18/17
10/18
18:10
10/18/17
18:10
Periodicals
Verizon targets spring start of delayed online TV service, Bloomberg says »

Verizon web TV…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 01

    Nov

STLD

Steel Dynamics

$36.44

0.27 (0.75%)

18:04
10/18/17
10/18
18:04
10/18/17
18:04
Hot Stocks
Steel Dynamics CEO optimistic conditions in place to benefit FY18 consumption »

CEO Mark Millet said:…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

CE

Celanese

$104.03

-0.24 (-0.23%)

18:03
10/18/17
10/18
18:03
10/18/17
18:03
Earnings
Celanese increases price for acetyls and engineered materials products »

Celanese will increase…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

STLD

Steel Dynamics

$36.44

0.27 (0.75%)

18:01
10/18/17
10/18
18:01
10/18/17
18:01
Earnings
Steel Dynamics reports Q3 ex-items EPS 66c, consensus 66c »

Reports Q3 revenue $2.4B,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

OPTT

Ocean Power

$2.00

0.56 (38.89%)

17:59
10/18/17
10/18
17:59
10/18/17
17:59
Syndicate
Ocean Power files to sell common stock in 'best efforts' offering »

No amount was provided.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Oct

TOSBF

Toshiba, also use TOSYY

$3.02

-0.03 (-0.98%)

, TOSYY

Toshiba, also use TOSBF

$18.20

-0.11 (-0.60%)

17:58
10/18/17
10/18
17:58
10/18/17
17:58
Periodicals
Japan regulators probing Toshiba reporting practices for FY16/17, Nikkei says »

Japan's Securities…

TOSBF

Toshiba, also use TOSYY

$3.02

-0.03 (-0.98%)

TOSYY

Toshiba, also use TOSBF

$18.20

-0.11 (-0.60%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PNW

Pinnacle West

$87.34

-0.42 (-0.48%)

17:53
10/18/17
10/18
17:53
10/18/17
17:53
Hot Stocks
Pinnacle West raises quarterly divided 6.1% to 69.5c per share »

Pinnacle West…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Nov

  • 05

    Nov

  • 05

    Nov

  • 05

    Nov

GILD

Gilead

$80.01

-0.23 (-0.29%)

17:46
10/18/17
10/18
17:46
10/18/17
17:46
Hot Stocks
FDA grants regulatory approval to Kite's Yescarta »

Kite, a Gilead company,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Oct

  • 26

    Oct

  • 06

    Nov

  • 12

    Feb

POT

Potash

$19.24

0.08 (0.42%)

, AGU

Agrium

$107.73

0.55 (0.51%)

17:37
10/18/17
10/18
17:37
10/18/17
17:37
Hot Stocks
Potash, Agrium: India approves proposed merger of equals transaction »

Potash Corporation of…

POT

Potash

$19.24

0.08 (0.42%)

AGU

Agrium

$107.73

0.55 (0.51%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VMI

Valmont

$160.85

1.9 (1.20%)

17:36
10/18/17
10/18
17:36
10/18/17
17:36
Earnings
Valmont lowers FY17 adjusted EPS view to $6.90-$7.04 from $7.06, consensus $7.09 »

Annual guidance was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.